DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)
MANUFACTURER: Novartis
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing's syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing's disease, a type of Cushing's syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing's syndrome (ECS), a type of Cushing's syndrome caused by the body overproducing cortisol on its own.
